Back to News
research

PAVmed Inc. (PAVM) Q4 2025 Earnings Call Transcript

Seeking Alpha
Loading...
2 min read
0 likes
Untitled design (12).png
Quantum News · Media Library

SA Transcripts159.16K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call PAVmed Inc. (PAVM) Q4 2025 Earnings Call March 30, 2026 8:30 AM EDT Company Participants Matthew Riley - Senior Director of Investor RelationsLishan Aklog - Chairman & CEODennis McGrath - President & CFO Conference Call Participants Jeremy Pearlman - Maxim Group LLC, Research DivisionEdward Woo - Ascendiant Capital Markets LLC, Research Division Presentation Operator Good morning, and welcome to the PAVmed's Fourth Quarter 2025 Business Update Conference Call. [Operator Instructions] This call is being recorded on Monday, March 30, 2026. I would now like to turn the conference over to Matt Riley, PAVmed's Vice President of Investor Relations. Please go ahead. Matthew RileySenior Director of Investor Relations Thank you, operator. Good morning, everyone. Thank you for participating in today's business update call. Joining me today on the call are Dr. Lishan Aklog, Chairman and CEO of PAVmed; along with Dennis McGrath, Chief Financial Officer. The press release announcing our business update and financial results is available on PAVmed's website. Please take a moment to read the disclaimers about forward-looking statements in the press release. The business update press release and the conference call all include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer and in our filings with the SEC. For a list and description of these and other important risks and uncertainties that may affect future operations, see Part 1, Item 1A entitled Risk Factors in PAVmed's most recent annual report on Form 10-K filed with the SEC and any subsequent updates filed in quarterly reports on Forms 10-Q and subsequent Forms 8-K. Except as required by law, PAVmed disclaims any intentions or obligations to publicly update or revise any

Read Original

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.